Call for more patient-centered drug development in oncology — NEJM

In an article in the New England Journal of Medicine (NEJM), published online on 3 July 2013, Dr Ethan Basch highlights the lack of information on how a drug will make patients feel in the US label of most new cancer drugs.  … Continue reading

EMA draft policy on access to clinical trial data

On Monday, 24 June 2013, the European Medicines Agency (EMA) published their draft policy on publication and access to clinical trial data.  The policy is open for public consultation until 30 September 2013. EMA were recently prevented from releasing clinical … Continue reading

New EMA guidance available for Parkinsons and Diabetes, CF endpoint workshop dates announced

In the past few weeks the European Medicines Agency has released updated guidance in a number of disease areas, including Parkinsons and diabetes, and they have published the dates of a workshop to discuss endpoints in development of new drugs … Continue reading

Cancer Research UK calls for improvement of the EU clinical trials directive

In an article published in The Telegraph on 14 February 2012 Professor Peter Johnson, chief clinician at Cancer Research UK, said that while the principles of the EU clinical trials directive were “sensible” the increased bureaucracy which has arisen from its … Continue reading